Literature DB >> 27216998

Caged xanthones: Potent inhibitors of global predominant MRSA USA300.

Pongkorn Chaiyakunvat1, Natthinee Anantachoke2, Vichai Reutrakul1, Chutima Jiarpinitnun1.   

Abstract

Total of 22 caged xanthones were subjected to susceptibility testing of global epidemic MRSA USA300. Natural morellic acid showed the strongest potency (MIC of 12.5μM). However, its potent toxicity diminishes MRSA therapeutic potential. We synthetically modified natural morellic acid to yield 13 derivatives (3a-3m). Synthetically modified 3b retained strong potency in MRSA growth inhibition, yet the toxicity was 20-fold less than natural morellic acid, permitting the possibility of using caged xanthones for MRSA therapeutic.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacterial invasion; Caged xanthones; Methicillin resistant Staphylococcus aureus; USA300

Mesh:

Substances:

Year:  2016        PMID: 27216998     DOI: 10.1016/j.bmcl.2016.05.030

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  Antibacterial activities of plant-derived xanthones.

Authors:  Xiaojia Liu; Jianzhong Shen; Kui Zhu
Journal:  RSC Med Chem       Date:  2021-12-21

2.  Transcriptional Analysis of the Effects of Gambogic Acid and Neogambogic Acid on Methicillin-Resistant Staphylococcus aureus.

Authors:  Xin Hua; Yue Jia; Qin Yang; Wanjiang Zhang; Zhimin Dong; Siguo Liu
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.